Globus Medical, Inc. (GMED)
84.66
-2.44
(-2.80%)
USD |
NYSE |
Nov 05, 10:24
Globus Medical EPS Diluted (Quarterly) : 1.103 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.103 |
| March 31, 2026 | 0.8995 |
| December 31, 2025 | 1.029 |
| September 30, 2025 | 0.8787 |
| June 30, 2025 | 1.486 |
| March 31, 2025 | 0.5399 |
| December 31, 2024 | 0.1897 |
| September 30, 2024 | 0.3754 |
| June 30, 2024 | 0.2319 |
| March 31, 2024 | -0.0526 |
| December 31, 2023 | 0.1082 |
| September 30, 2023 | 0.0087 |
| June 30, 2023 | 0.567 |
| March 31, 2023 | 0.4807 |
| December 31, 2022 | 0.4898 |
| September 30, 2022 | 0.4677 |
| June 30, 2022 | 0.5306 |
| March 31, 2022 | 0.3659 |
| December 31, 2021 | 0.145 |
| September 30, 2021 | 0.4521 |
| June 30, 2021 | 0.4015 |
| March 31, 2021 | 0.4426 |
| December 31, 2020 | 0.5222 |
| September 30, 2020 | 0.44 |
| June 30, 2020 | -0.2137 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.254 |
| December 31, 2019 | 0.4423 |
| September 30, 2019 | 0.3752 |
| June 30, 2019 | 0.3757 |
| March 31, 2019 | 0.3276 |
| December 31, 2018 | 0.3616 |
| September 30, 2018 | 0.3458 |
| June 30, 2018 | 0.4431 |
| March 31, 2018 | 0.3934 |
| December 31, 2017 | 0.25 |
| September 30, 2017 | 0.26 |
| June 30, 2017 | 0.2931 |
| March 31, 2017 | 0.2956 |
| December 31, 2016 | 0.25 |
| September 30, 2016 | 0.27 |
| June 30, 2016 | 0.27 |
| March 31, 2016 | 0.29 |
| December 31, 2015 | 0.39 |
| September 30, 2015 | 0.28 |
| June 30, 2015 | 0.25 |
| March 31, 2015 | 0.26 |
| December 31, 2014 | 0.29 |
| September 30, 2014 | 0.24 |
| June 30, 2014 | 0.22 |
| March 31, 2014 | 0.22 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5293 |
| Merit Medical Systems, Inc. | 0.7008 |
| Teleflex, Inc. | 2.283 |
| Glaukos Corp. | 0.033 |
| The Cooper Cos., Inc. | 2.238 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 151.57M |
| Revenue (Quarterly) | 789.61M |
| Total Expenses (Quarterly) | 638.04M |
| Enterprise Value | 11.21B |
| Gross Profit Margin (Quarterly) | 65.92% |
| Profit Margin (Quarterly) | 19.20% |
| Earnings Yield | 4.62% |
| Operating Earnings Yield | 5.84% |
| Normalized Earnings Yield | 4.832 |